Prospective Observational Multicenter Study of Patients With AH and CKD Markers in Kazakhstan (PROGRESS-CKD)

Study Summary

Multicenter, non-interventional PRospective Observational study with retrospective analysis to describe the rate of CKD diaGnosis in patients with aRtErial hypErtenSion and CKD markerS in Kazakhstan

Conditions

Rate of CKD Diagnosis in Patients With AH and CKD Markers Demographic and Clinical Characteristics for Those Patients Routine Therapy Before and After the Diagnosis of CKD

Interventions / Drugs

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment1282 participants

Primary Completion—

Lead SponsorAstraZeneca

Data Retrieved2026-04-11 02:55:19.910228+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.